{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:02:34Z","timestamp":1783393354550,"version":"3.54.6"},"reference-count":51,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.clml.2020.02.021","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T12:19:02Z","timestamp":1583497142000},"page":"542-547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Incidence of Venous Thromboembolism and Impact on Survival in Hodgkin Lymphoma"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7523-8599","authenticated-orcid":false,"given":"Onur","family":"Kirkizlar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugcan","family":"Alp Kirkizlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif Gulsum","family":"Umit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4528-7194","authenticated-orcid":false,"given":"Ismail","family":"Asker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Baysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkan","family":"Bas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedanur Karaman","family":"Gulsaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ufuk","family":"Demirci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Muzaffer","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2020.02.021_bib1","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1182\/blood-2010-01-258624","article-title":"Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events","volume":"115","author":"Caruso","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.02.021_bib2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.clml.2020.02.021_bib3","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","article-title":"Epidemiology of cancer-associated venous thrombosis","volume":"122","author":"Timp","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.02.021_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41408-018-0096-1","article-title":"Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization","volume":"8","author":"Hohaus","year":"2018","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2020.02.021_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jjco\/hyr184","article-title":"Japan Cancer Surveillance Research Group: cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project","volume":"42","author":"Matsuda","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.clml.2020.02.021_bib6","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.02.021_bib7","first-page":"7","article-title":"Cancer Statistics","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 1","key":"10.1016\/j.clml.2020.02.021_bib8","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0049-3848(13)70024-0","article-title":"Mechanisms of thrombosis in cancer","volume":"131","author":"Falanga","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.clml.2020.02.021_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2302\/kjm.2014-0017-RE","article-title":"Thrombosis in lymphoma patients and in myeloma patients","volume":"64","author":"Yokoyama","year":"2015","journal-title":"Keio J Med"},{"key":"10.1016\/j.clml.2020.02.021_bib10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.thromres.2016.05.008","article-title":"Incidence of venous thromboembolism in patients with non-Hodgkin lymphoma","volume":"143","author":"Sanfilippo","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.clml.2020.02.021_bib11","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.clml.2020.02.021_bib12","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1200\/JCO.2009.22.3271","article-title":"Assessing risk of venous thromboembolism in the patient with cancer","volume":"27","author":"Khorana","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.02.021_bib13","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3324\/haematol.2017.169060","article-title":"Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study","volume":"102","author":"Van Es","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2020.02.021_bib14","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/jth.13378","article-title":"Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer","volume":"14","author":"Mansfield","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.clml.2020.02.021_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.thromres.2016.12.013","article-title":"The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer","volume":"150","author":"Van Es","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.clml.2020.02.021_bib16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/1076029617699088","article-title":"Performance of Khorana risk score for prediction of venous thromboembolism in patients with hepatocellular carcinoma","volume":"24","author":"Wang","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.clml.2020.02.021_bib17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4143\/crt.2014.266","article-title":"Cross-sectional study of patients with diffuse large B-cell lymphoma: assessing the effect of host status, tumor burden and inflammatory activity on venous thromboembolism","volume":"48","author":"Lim","year":"2016","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.clml.2020.02.021_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12032-017-1065-4","article-title":"Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score","volume":"35","author":"Rupa-Matysek","year":"2018","journal-title":"Med Oncol"},{"key":"10.1016\/j.clml.2020.02.021_bib19","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/ajh.24466","article-title":"Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients","volume":"91","author":"Antic","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2020.02.021_bib20","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1002\/cam4.1540","article-title":"Evaluation of the ThroLy score for the prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies in clinical practice","volume":"7","author":"Rupa-Matysek","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.clml.2020.02.021_bib21","first-page":"1860","article-title":"Report of the Committee on Hodgkin's Disease Staging Classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"10.1016\/j.clml.2020.02.021_bib22","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A\u00a0prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2020.02.021_bib23","series-title":"Physical Status: The Use and Interpretation of Anthropometry: Report of a World Health Organization (WHO) Expert Committee","year":"1995"},{"key":"10.1016\/j.clml.2020.02.021_bib24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clml.2020.02.021_bib25","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/hrt.2010.198275","article-title":"Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital: summary of the NICE guideline","volume":"96","author":"Hill","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.clml.2020.02.021_bib26","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.6004\/jnccn.2013.0163","article-title":"Venous thromboembolic disease","volume":"11","author":"Streiff","year":"2013","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"issue":"2 Suppl","key":"10.1016\/j.clml.2020.02.021_bib27","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","article-title":"Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kahn","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.clml.2020.02.021_bib28","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.02.021_bib29","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.thromres.2012.03.019","article-title":"Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: results from a prospective cohort study with Asian population","volume":"130","author":"Park","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.clml.2020.02.021_bib30","first-page":"442","article-title":"Prevalence and patterns of symptomatic thromboembolism in oncohematology","volume":"83","author":"Sgarabotto","year":"1998","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2020.02.021_bib31","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/cncr.23062","article-title":"Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients","volume":"110","author":"Khorana","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2020.02.021_bib32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.thromres.2017.02.011","article-title":"Venous thrombosis in children and adolescents with Hodgkin lymphoma in Sweden","volume":"152","author":"Sch\u00f6nning","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.clml.2020.02.021_bib33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1600-0609.1995.tb00214.x","article-title":"Deep venous thrombosis and pulmonary artery embolism in high grade non- Hodgkin\u2019s lymphoma: incidence, causes and prognostic relevance","volume":"54","author":"Ottinger","year":"1995","journal-title":"Eur J Hematol"},{"key":"10.1016\/j.clml.2020.02.021_bib34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.thromres.2010.08.017","article-title":"Increased risk of venous thromboembolism in patients with primary mediastinal large B-cell lymphoma","volume":"126","author":"Lekovic","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.clml.2020.02.021_bib35","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.thromres.2007.12.006","article-title":"Thromboembolism in children with lymphoma","volume":"122","author":"Athale","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.clml.2020.02.021_bib36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2257.1999.00250.x","article-title":"Thrombosis, markers of thrombotic risk, indwelling central venous catheters and antithrombotic prophylaxis using low-dose warfarin in subjects with malignant disease","volume":"21","author":"Ratcliffe","year":"1999","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.clml.2020.02.021_bib37","first-page":"577","article-title":"Activation of coagulation and deep vein thrombosis after bone marrow harvesting and insertion of a Hickman-catheter in ABMT patients with malignant lymphoma","volume":"17","author":"Sletnes","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2020.02.021_bib38","first-page":"235","article-title":"Catheter-related thrombosis in patients with refractory lymphoma undergoing autologous stem cell transplantation","volume":"7","author":"Conlan","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2020.02.021_bib39","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1538-7836.2008.03017.x","article-title":"Current perspective of venous thrombosis in the upper extremity","volume":"6","author":"Flinterman","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.clml.2020.02.021_bib40","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1182\/blood-2010-02-270116","article-title":"Prediction of venous thromboembolism in cancer patients","volume":"116","author":"Ay","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.02.021_bib41","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/annonc\/mdr524","article-title":"Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the \u2018SENDO experience\u2019","volume":"23","author":"Mandala","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2020.02.021_bib42","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1200\/JCO.2011.35.5669","article-title":"High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis","volume":"29","author":"Moore","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.02.021_bib43","article-title":"Khorana score and histotype predicts incidence of early venous thromboembolism in non-Hodgkin lymphomas. A pooled-data analysis of 12 clinical trials of Fondazione Italiana Linfomi (FIL)","author":"Santi","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clml.2020.02.021_bib44","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMoa1108898","article-title":"Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer","volume":"366","author":"Agnelli","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2020.02.021_bib45","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/jth.13594","article-title":"Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer: comment","volume":"15","author":"Noble","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.clml.2020.02.021_bib46","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/jth.13205","article-title":"ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer","volume":"14","author":"Pepin","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.clml.2020.02.021_bib47","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/aje\/kwq066","article-title":"Body height and risk of venous thromboembolism: the Troms\u00f8 Study","volume":"171","author":"Braekkan","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clml.2020.02.021_bib48","first-page":"1011","article-title":"Deep venous thrombosis during therapy for Hodgkin\u2019s disease","volume":"69","author":"Seifter","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.clml.2020.02.021_bib49","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.3390\/ijms20215503","article-title":"Immune and inflammatory cells of the tumor microenvironment represent novel therapeutic targets in classical Hodgkin lymphoma","volume":"20","author":"Calabretta","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clml.2020.02.021_bib50","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/annonc\/mdz168","article-title":"thrombosis as a treatment complication in Hodgkin lymphoma patients: a comprehensive analysis of three prospective randomized German Hodgkin Study Group (GHSG) trials","volume":"30","author":"Borchmann","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2020.02.021_bib51","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1634\/theoncologist.2015-0361","article-title":"A\u00a0validated risk score for venous thromboembolism is predictive of cancer progression and mortality","volume":"21","author":"Kuderer","year":"2016","journal-title":"Oncologist"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226502030118X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226502030118X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:34:38Z","timestamp":1761870878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S215226502030118X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S215226502030118X"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2020.02.021","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Incidence of Venous Thromboembolism and Impact on Survival in Hodgkin Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2020.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}